PM, CMs to be likely vaccinated in second phase, politicians above 50 in third stage daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.
Business Today MindRush 2021: Top corporate honchos to discuss state of economy, the way ahead
Business Today MindRush 2021: Bharat Biotech s CMD Krishna Ella will discuss the future of healthcare post-COVID with Thyrocare MD A Velumani and Public Health Foundation of India President Srinath Reddy on day one of the event
BusinessToday.In | January 22, 2021 | Updated 11:05 IST
Business Today MindRush will held on January 22 & 23
The who s who of corporate world will come together at the Business Today MindRush 2021 on 22-23 January to discuss the state of economy, global pandemic and the way ahead.
Former Niti Aayog Vice-Chairman and economist Arvind Panagariya will speak on how to kickstart the economy disrupted by the pandemic, while Hindustan Unilever CMD will give his views on navigating the business through chaos and confusion.
He added that the antibody stability for six months found in the study is a good sign.
Reacting to the conclusions drawn from the survey, immunologist Satyajit Rath noted that the research paper treats sero-positivity, or the presence of antibodies, as a surrogate for exposure to the virus, and sero-negativity as an evidence of protection against the pathogen conferred by smoking, vegetarianism, and other factors.
“Nobody would interpret sero-negativity as evidence of protection, but only as lack of exposure,” Rath told PTI.
Classically, sero-positivity is interpreted as evidence of prior exposure, not as evidence of susceptibility, he explained.
“All interpretations about so-called roles for blood groups, smoking, and vegetarianism appear to be based on this incorrect interpretation,” Rath, from Delhi’s National Institute of Immunology (NII), added.
New Delhi, Jan 18: India’s Covid-19 vaccination hasn't got off to a smooth start, with the numbers after two days remaining low due to a combination of factors ranging from technical glitches in the Co-WIN software to a certain degree of vaccine hesitancy among recipients.